Newsletter | February 20, 2024

02.20.24 -- AI In Drug Discovery And Development – Will It Live Up To The Hype?

FEATURED EDITORIAL

AI In Drug Discovery And Development: Will It Live Up To The Hype?

While AI may soon transform the drug discovery and development process, there are still several barriers, both technical and ethical, to the rise of AI in biopharma.

INDUSTRY INSIGHTS

Continuous Processing For Enhanced Monoclonal Antibody Production

mAbs have only recently been leveraged for advanced bioprocessing techniques. Explore highlights from a webinar where experts discussed their unique collaboration for the continuous processing of mAbs.

Predictive Modeling Of Viscosity Behavior Using Artificial Neural Networks

Discover a modeling approach employing artificial neural networks using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.

Mitigating Hidden Risks: Extractables And Leachables

Everything from glass or plastic bottles to the ink used in labels can leach unwanted contaminants. The first challenge chemists address is to narrow the focus onto the most likely suspects.

Complex Molecules, Complex Problems

The support of an experienced CDMO is critical to overcoming complexity when working with a highly potent active pharmaceutical ingredient (HPAPI) and when solving solubility challenges.

From Nanoformed Powder To 3D Printable Ink

3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials.

Approaches To Establishing A Perfusion Mimic Process

We demonstrate how high throughput perfusion mimic processes can be achieved in microbioreactors with good consistency amongst the replicates and with sustained cell viability and protein production.

Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics

Learn about the key stages of drug discovery and screening, as well as how to overcome bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.

SPONSOR

MOST POPULAR NEWS

VantAI Enters Collaboration With Bristol Myers Squibb To Accelerate Molecular Glues

HTuO Biosciences Joins Johnson & Johnson Innovation - JLABS

Edgewise Receives U.S. FDA Fast Track Designation For EDG-5506

Iambic Therapeutics Announces New Research Published In Nature Machine Intelligence

High Content Screening For Biologics A Revolutionary Approach To Drug Discovery

Ono Collaborates With Shattuck Labs To Generate Bifunctional Fusion Proteins

CalciMedica Announces FDA Clearance Of IND Application For Phase 2 Trial Of Auxora

GSK Exercises Option To License Elsie Biotechnologies’ Discovery Platform

Y Biologics Transfers CAR-T/NK Target Antibody Sequence License Tech To Vaxcell Bio

Atara Biotherapeutics Announces Submission Of IND Application For ATA3219

Krystal Biotech Receives FDA Fast Track Designation For Inhaled Oncology Candidate KB707

SOLUTIONS

Solid Form Services

Biocatalysis For Cost-Efficient, Environmentally Friendly Manufacturing